LATEST

• BUSINESS Meiji Rolls Out 2-Dose Vial of COVID-19 Vaccine Kostaive
  September 29, 2025

• REGULATORY Japan Says It’s Too Early to Gauge Impact of US Pharma Tariffs
  September 29, 2025

• ORGANIZATION Generic Use Rate Hits Record 89.2% in April-June: JGA
  September 29, 2025

• COLUMN The Keen Eye: Awareness as a Leadership Cornerstone
  September 29, 2025

• ORGANIZATION Kenporen Proposes Higher Copays for Choosing Costlier Drugs
  September 26, 2025

• ORGANIZATION Japan Wholesalers’ Profit Margin Improves to 1.11% in FY2024
  September 26, 2025

• BUSINESS Mochida Sees Domestic Biosimilar Supply Gains in And Pharma Tie-Up
  September 26, 2025

• ORGANIZATION JPMA Think Tank Chief Pledges to Back Policy Debates with Evidence
  September 26, 2025

• REGULATORY Pharma Support Needed to Bridge Biotech’s “Valley of Death”: Council Member
  September 26, 2025

• REGULATORY Cost-Effectiveness Talks Continue on Expanding HPV Vaccinations to Males
  September 26, 2025

• BUSINESS Fujifilm Launches US$3.2 Billion Biologics Plant in North Carolina
  September 26, 2025

• BUSINESS MEDRx/DWTI Clinch US FDA Approval for Lidocaine Patch
  September 26, 2025

• ORGANIZATION Japanese Pharma-Cosmetic Union Breaks from UA Zensen, Set to Join Rengo
  September 25, 2025

• ORGANIZATION JPMA to Overhaul Guideline for Handling Drug Inquiries This Fall: Consultation Chair
  September 25, 2025

• BUSINESS Nippon Zoki Shooting for 50% Overseas Sales by FY2035
  September 25, 2025

• BUSINESS Australia Clears Leqembi after Tribunal Review
  September 25, 2025

• BUSINESS Taiho Hooks Up with Guardant Health in Biomarker Search
  September 25, 2025

• BUSINESS GE HealthCare to Develop Lantheus’ Prostate Cancer PET Agent in Japan
  September 25, 2025

• ORGANIZATION Generic Use Rate at 89.6% in April: Payer
  September 25, 2025

• BUSINESS Eisai Settles US Lenvima Suit with Dr. Reddy’s, Generic Launch Barred Until 2030
  September 25, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• Next ›
• 最終 »